Aptorum Group Limited
APM
$1.99
$0.12996.98%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
12/4/2023
-
Ticker Report
11/18/2023
-
Ticker Report
11/16/2023
-
Business Wire
10/30/2023
-
Ticker Report
10/14/2023
-
Ticker Report
9/13/2023
-
Ticker Report
9/6/2023
-
Zolmax
8/28/2023
-
SeekingAlpha.com: All News
8/17/2023
-
Ticker Report
8/10/2023
-
Seeking Alpha - Healthcare
8/10/2023
-
Business Wire
8/5/2023
-
Insider Monkey
7/5/2023
-
Ticker Report
7/5/2023
-
Zolmax
6/22/2023
-
Business Wire
6/15/2023
-
Ticker Report
6/14/2023
-
Zolmax
6/9/2023
-
Business Wire
5/18/2023
-
InvestorPlace
5/15/2023
-
Ticker Report
5/13/2023
-
Ticker Report
5/5/2023
-
Business Wire
5/3/2023
-
InvestorPlace
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, April 28, 2023
Period Date
Saturday, December 31, 2022
Next Filing
(est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
44 20 8092 9299
Address
17 Hanover Square
London, W1S 1BN
London, W1S 1BN
Country
Year Founded
Business Description
Sector
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The...
more
